I’m interested in all things concerning T cells. I received my Ph.D. with studies of T cell cytotoxicity and activation. Currently I’m working on how different IkBs influence T cell proliferation and survival.
Citation | Link |
---|---|
Hydrolysis of tumor cell lipids after cytotoxic T lymphocyte (CTL)-mediated death. Bryce N. Alves, Jeff Leong, David Tamang, Viki Elliott, Mark Lowe, and Dorothy Hudig. Int Immunol. 2009 May;21(5):543-53. |
PubMed |
Pancreatic lipase-related protein 2 (PLRP2) induction by IL-4 in CTLs and reevaluation of the negative effects of its gene ablation on cytotoxicity. Bryce N. Alves, Jeff Leong, David Tamang, Viki Elliott, Jillian Edelnant, Doug Redelman, Cherrie A. Singer, Andy R Kuhn, Rita Miller, Mark E Lowe, and Dorothy Hudig. J Leukoc Biol. 2009 Sep;86(3):701-12. |
PubMed |
Lipid-dependent cytotoxicity by the lipase PLRP2 and by PLRP2-positive cytotoxic T lymphocytes (CTLs). Bryce N. Alves, Kristen Marshall, David L.Tamang, Jeff Leong, Doug Redelman, Viki Elliott, Mark E. Lowe, and Dorothy Hudig. Cell Biochem Funct. 2009 Jul;27(5):296-308 |
PubMed |